Zanamivir

（重定向自Relenza）

Zanamivir INN /zəˈnæmᵻvɪər/ is a neuraminidase inhibitor used in the treatment and prophylaxis of influenza caused by influenza A and B viruses. It was developed by the Australian biotech firm Biota Holdings. It was licensed to Glaxo in 1990 and approved in the US in 1999, only for use as a treatment for influenza. In 2006, it was approved for prevention of influenza A and B. Zanamivir was the first neuraminidase inhibitor commercially developed. It is currently marketed by GlaxoSmithKline under the trade name Relenza as a powder for oral inhalation.

单词	Relenza
释义	Relenza 英语百科 Zanamivir （重定向自Relenza） Zanamivir INN /zəˈnæmᵻvɪər/ is a neuraminidase inhibitor used in the treatment and prophylaxis of influenza caused by influenza A and B viruses. It was developed by the Australian biotech firm Biota Holdings. It was licensed to Glaxo in 1990 and approved in the US in 1999, only for use as a treatment for influenza. In 2006, it was approved for prevention of influenza A and B. Zanamivir was the first neuraminidase inhibitor commercially developed. It is currently marketed by GlaxoSmithKline under the trade name Relenza as a powder for oral inhalation.
随便看	induement induements indue in due season in due succession in due time induflux method induhvidual induire induit induition indulcate indulge indulged in indulge in indulge in a fling at indulge in the wildest fantasy indulge in verbiage indulgement indulgements indulgencer indulgenciaries indulgencies indulgence indulgency